India's Shilpa Medicare can make 100-200 million doses of Covid-19 shot
Indian drug maker Shilpa Medicare Ltd has the production capacity to make 100-200 million doses of a recombinant vaccine for COVID-19 , a company executive told Reuters on Wednesday. The company's shares jumped as much as 9.2% on India's National Stock Exchange following the news. Read More